Announcment under Regulation 30(LODR)- Change in Mangement PDf is attched.

Date: July 17, 2026 The Bombay Stock Exchange (BSE Limited) Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai- 400001 Scrip Name: AMWILL HEALTH CARE LIMITED. Company Scrip Code.: 544353 Re: Disclosure under Regulation 30 and 42 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations") read with SEBI Master Circular no. (Ref: HO/49/14/14(7)2025-CFD- POD2/I/3762/2026) January 30, 2026 (“SEBI Master Circular”). Subject: Outcome of the meeting of the Board of Directors held on July 17, 2026. Time of commencement: 03:34 P.M. (IST) / Time of conclusion: 4:00 P.M. (IST). Dear Sir/Madam, Pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”), we hereby inform you that the Board of Directors of the Company, at its meeting held on today, July 17, 2026 has considered and approved the following: 1) Re-appointment of Mr. Tarun Gandhi (DIN: 07854699), as a Managing Director & Key Managerial Personnel, on the recommendations of the Nomination, & Remuneration Committee, for a period of consecutive 05 (five) years, commencing from January 27, 2027 till January 26, 2032, subject to approval of the shareholders of the Company by way of special resolution at the ensuing 09th Annual General Meeting (“AGM”) of the Company; 2) Re-appointment of Mr. Anand Gandhi (DIN: 07854706), as a Managing Director & Key Managerial Personnel, on the recommendations of the Nomination, & Remuneration Committee, for a period of consecutive 05 (five) years, commencing from January 27, 2027 till January 26, 2032, subject to approval of the shareholders of the Company by way of special resolution at the ensuing 09th Annual General Meeting (“AGM”) of the Company; 3) Annual Report for the financial year 2025-26, comprising the Audited Financial Statements, Board's Report and Annexures thereto, including Management Discussion and Analysis Report, and Corporate Social Responsibility Report for FY26: 4) Convening 09th Annual General Meeting ("AGM") on Friday, August 14, 2026 at 01:00 p.m. (IST) through Video Conferencing/ Other Audio-Visual Means ("VC"/"OAVM") facility and notice thereof; 5) Fixing of Saturday, August 08, 2026, as the "Cut-Off Date/Record date" to ascertain the names of members who will be entitled to attend and vote in e-voting at the 09th AGM. 6) Facility to cast votes by electronic means, i.e., remote e-Voting and e-Voting during the e- AGM, through National Securities Depository Limited (NSDL), on all the resolutions mentioned in the Notice convening 09th AGM. The remote e-Voting facility will be available during following period at https://www.evoting.nsdl.com: Commencement of remote e-Voting: 09:00 A.M. (IST) on Tuesday, August 11, 2026 End of remote e-Voting 05:00 P.M. (IST) on, Thursday, August 13, 2026 In compliance with the provisions of Sections 101 and 136 of the Companies Act, 2013 read with Rule 18 of the Companies (Management and Administration) Rules, 2014 and in line with the MCA Circulars and the SEBI Circulars, the Notice of the 09th AGM along with Annual Report for FY26, will be sent to the eligible shareholders and all concerned in due course of time, only through electronic mode on the e-mail IDs registered with the Company/ Depositories/ Depository Participants and will also be disseminated on the websites of the Company and the stock exchange, i.e., the BSE Limited (BSE). The details such as manner of: (i) registering / updating email addresses, (ii) casting vote through remote e-Voting and e-Voting during the AGM and (iii) attending the AGM through VC / OAVM will be set out in the Notice of the AGM. Notice of 09th AGM and Annual Report 2025-26 will be available on the Company's website viz. www.amwillhealthcare.com and website of the Stock Exchanges, i.e., the BSE Limited at www.bseindia.com. 7) Appointment of Mr. Saurabh Talwar (COP No. 13338), practicing company secretary, as the Scrutinizer, to scrutinize remote e-Voting process and e-Voting during the 09th AGM in a fair and transparent manner. This disclosure is being made in compliance with Regulation 30 of the SEBI Listing Regulations and is submitted for your information and record, will be available on the website of the Company www.amwillhealthcare.com. Thanking You. FOR AMWILL HEALTH CARE LIMITED Anshu Anshuman Company secretary and compliance Officer ACS65515 Address: No. 90,4th Floor, 2nd Main, 7th Cross, Chamrajpet, Bangalore, Karnataka, India, 560018 Enclosed: 1) Annexure A Annexure A Details with respect to Change in Key Managerial Personnel (Resignation and appointment of director) under Regulation 30 read with Part A of Schedule III of the Listing Regulations, SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 9, 2015 and SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated 11th November 2024: S.N. Particulars Mr. Tarun Gandhi (DIN: Mr. Anand Gandhi (DIN: 07854699) as Managing 07854706) as Managing Director Director 1 Reason for Change Re-appointment Re-appointment viz. appointment, resignation, removal, death or otherwise. 2 Date of appointment/ Date of re-appointment as Date of re-appointment as reappointment/ Managing Director: January Managing Director: January cessation 26, 2027 26, 2027 (as applicable) 3 Term of appointment/ Mr. Tarun Gandhi (DIN: Mr. Anand Gandhi (DIN: reappointment 07854699) as Managing 07854706) as Managing Director shall be reappointed Director shall be reappointed as a Managing Director, to not as a Managing Director, to not liable to retire by rotation and liable to retire by rotation and a Key Managerial Personnel, a Key Managerial Personnel, for a period of 05 (five) for a period of 05 (five) consecutive years consecutive years commencing from January 27, commencing from January 27, 2027 till January 26, 2032. 2027 till January 26, 2032. Detailed terms of re- Detailed terms of re- appointment and maximum appointment and maximum remuneration payable to Mr. remuneration payable to Mr. Tarun Gandhi as Managing Anand Gandhi (as Managing Director, may be referred Director, may be referred from the Notice convening from the Notice convening 09th AGM. 09th AGM. 4 Brief profile (in case Provided below Provided below of appointment) 5 Relation with Relative of Mr. Anand Gandhi Relative of Mr. Tarun Gandhi directors of company (in case of appointment) 6 Information as Mr. Tarun Gandhi (DIN: Mr. Anand Gandhi (DIN: required pursuant to 07854699) is not debarred 07854706) is not debarred BSE Circular No. from holding the office of from holding the office of LIST/COMP/14/2018- Director by virtue of any Director by virtue of any 19 and NSE Circular SEBI order or any other such SEBI order or any other such No. NSE/ authority. authority. CML/2018/24 dated June 20, 2018. Brief Profile Mr. Tarun Gandhi (DIN: 07854699) as Mr. Anand Gandhi (DIN: 07854706) as Managing Director Managing Director Mr. Tarun Gandhi holds a bachelor’s degree in Mr. Anand Gandhi holds a bachelor’s and commerce (advanced financial accounting and master’s degree in pharmacy (pharmaceutics) with management accounting) with honors from honours from Rajiv Gandhi University of Health Bangalore Sciences, Karnataka. University. Mr. Anand Gandhi holds experience of more than Mr. Tarun Gandhi holds experience of more than a a decade in brand placement, marketing and sales decade in financial management, accounts and enhancing product visibility in the management and business development. Hence, dermatology segment of the pharmaceutical meets all such requirements for this role. industry. Hence, meets all such requirements for this role